Sh­iono­gi to pro­vide glob­al ac­cess to its an­tibi­otics, with fo­cus on poor coun­tries, as re­sis­tance fears grow

As the world faces a grow­ing chal­lenge of pathogens re­sis­tant to an­tibi­otics, Sh­iono­gi and the GARDP have com­mit­ted to an ex­e­cu­tion of a li­cense and tech­nol­o­gy trans­fer agree­ment with the Clin­ton Health Ac­cess Ini­tia­tive (CHAI).

Ac­cord­ing to Sh­iono­gi, the col­lab­o­ra­tion agree­ment will aim to in­crease ac­cess to an­tibi­otics for coun­tries around the world, with an em­pha­sis on low­er- and mid­dle-in­come na­tions. The agree­ment will fo­cus on ce­fide­ro­col, an an­tibi­ot­ic for the treat­ment of se­ri­ous Gram-neg­a­tive bac­te­r­i­al in­fec­tions.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER